Severe hypoglycemia in users of sulfonylurea antidiabetic agents and antihyperlipidemics.
CONCLUSIONS: Concomitant therapy with a sulfonylurea and fibrate is associated with an often delayed increased rate of severe hypoglycemia. This article is protected by copyright. All rights reserved.
PMID: 26566262 [PubMed - as supplied by publisher]
Source: Clinical Pharmacology and Therapeutics - Category: Drugs & Pharmacology Authors: Leonard CE, Bilker WB, Brensinger CM, Han X, Flory JH, Flockhart DA, Gagne JJ, Cardillo S, Hennessy S Tags: Clin Pharmacol Ther Source Type: research
More News: Cholesterol | Drugs & Pharmacology | Fenofibrate | Gemfibrozil | Glimepiride | Glipizide | Glyburide | Health | International Medicine & Public Health | Medicaid | Statin Therapy | Study | Tricor